We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FNB:NYSEF.N.B. Corporation Analysis

Data as of 2026-05-20 - not real-time

$17.13

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

F.N.B. Corp. is trading at $17.13, comfortably above its 20‑day SMA of 17.61 and the 50‑day SMA of 17.14, confirming a bullish price structure despite a modest RSI of 43.5 that signals neutral momentum. The MACD, however, has turned negative with the line below the signal, introducing a short‑term bearish bias that aligns with the stock hovering near the computed support of $16.99. The 30‑day volatility of roughly 24% and a beta above 1 suggest the share can swing sharply, a factor to watch for tactical traders. Fundamentally, the company posts a forward PE of 8.7 and a price‑to‑book below 1, positioning it well beneath the industry PE average of 16.5 and indicating relative cheapness. A dividend yield of 3.0% coupled with a payout ratio under 30% underscores a sustainable income stream, while the DCF‑derived fair value of $16.44 hints the market may be pricing a modest premium. Recent recognition as a Top Workplace in South Carolina adds a positive, albeit peripheral, narrative to the company's brand.
Analyst consensus points to a median target of $21, implying roughly 20% upside from current levels and reinforcing the notion of undervaluation relative to earnings potential. The bank’s strong operating margin of 42% and 9.6% revenue growth support this upside thesis, especially as cash balances exceed $2.7 billion, offsetting its $4.6 billion debt load. With the broader market in an “Extreme Greed” phase, the stock benefits from favorable sentiment but must navigate the regional banking sector’s medium‑level credit and regulatory risks. Overall, the blend of solid fundamentals, attractive yield, and technical bullishness makes FNB a compelling hold with upside potential for patient investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near technical support
  • Bearish MACD signal
  • Attractive dividend yield

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Analyst upside potential
  • Strong revenue growth and margins
  • Undervalued valuation multiples

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Sustainable dividend payout
  • Consistent profitability
  • Long‑term valuation upside

Key Metrics & Analysis

Financial Health

Revenue Growth9.60%
Profit Margin34.08%
P/E Ratio10.6
ROE8.85%
ROA1.17%
P/B Ratio0.9
Op. Cash Flow$569.0M
Industry P/E16.5

Technical Analysis

TrendBullish
RSI43.5
Support$16.99
Resistance$18.34
MA 20$17.61
MA 50$17.14
MA 200$16.78
MACDBearish
VolumeStable
Fear & Greed Index89.18

Valuation

Fair Value$16.44
Target Price$20.63
Upside/Downside20.40%
GradeFair
TypeBlend
Dividend Yield3.04%

Risk Assessment

Beta1.18
Volatility24.24%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.